|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US10632150||CMP DEV LLC||Potassium phosphates composition for injection||
(16 years from now)
Treatment: Potassium phosphates injection is indicated as a source of phosphorus in intravenous fluids to correct hypophosphatemia in adults and pediatric patients 12 years of age and older
|4.5GM/15ML (300MG/ML);2.65GM/15ML (175MG/ML)||SOLUTION;INTRAVENOUS||Prescription|
Click on the highlighted region to filter.